Blood cancer sufferers to be offered pioneering new immunity drugs as 'standard care' on NHS following trial success with patients who did not respond to other drugs
by dailym.ai
dailym.ai— Watchdogs last week gave the green light for pembrolizumab after studies suggested patients with Hodgkin's lymphoma on it lived longer than those given radiotherapy and chemotherapy.
dailym.ai—Migraine drug could be offered to facial flush sufferers after success in trial. Around one in 20 people in the UK have the skin condition rosacea, which causes a hot and red face as well as spots.
dailym.ai—Former Covid jab tsar tells NHS to launch experimental cancer vaccine trials with pioneering technology that trains the immune system how to hunt malignant cells. Dame Kate said that the experimental technology - which trains the immune system to hunt out cancer cells - will be 'ultimately how we are going to treat this terrible disease'.
Independent.ie—‘I was told I had aggressive cancer on Christmas Day, but now I am disease-free’ – cancer patient reveals how drug trial treatment gave her hope. It should have been an occasion of festive celebration, but on Christmas Day 2019 Sandra Whelan received the devastating news that she had an aggressive form of kidney cancer.